Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EDOXABAN vs EFAVIRENZ: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EDOXABAN vs EFAVIRENZ: Safety Overview

Metric EDOXABAN EFAVIRENZ
Total FAERS Reports 8,334 7,893
Deaths Reported 992 962
Death Rate 11.9% 12.2%
Hospitalizations 4,729 1,528
Average Patient Age 77.2 yrs 40.7 yrs
% Female Patients 46.5% 37.7%
FDA Approval Date Jan 8, 2015 Apr 27, 2018
Manufacturer Daiichi Sankyo Inc. Camber Pharmaceuticals, Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued